Log in to save to my catalogue

A novel isoform of pro-interleukin-18 expressed in ovarian tumors is resistant to caspase-1 and -4 p...

A novel isoform of pro-interleukin-18 expressed in ovarian tumors is resistant to caspase-1 and -4 p...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_66926031

A novel isoform of pro-interleukin-18 expressed in ovarian tumors is resistant to caspase-1 and -4 processing

About this item

Full title

A novel isoform of pro-interleukin-18 expressed in ovarian tumors is resistant to caspase-1 and -4 processing

Publisher

London: Nature Publishing Group UK

Journal title

Oncogene, 2004-09, Vol.23 (45), p.7552-7560

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Interleukin-18 (IL-18) is a proinflammatory cytokine synthesized as a 24 kDa inactive precursor (pro-IL-18) by several cell types, and is processed to a bioactive molecule of 18 kDa by the proteinases caspase-1 or caspase-4. All ovarian carcinoma cell lines express pro-IL-18, only in some instances coexpress caspase-1, and always express caspase-4;...

Alternative Titles

Full title

A novel isoform of pro-interleukin-18 expressed in ovarian tumors is resistant to caspase-1 and -4 processing

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_66926031

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_66926031

Other Identifiers

ISSN

0950-9232

E-ISSN

1476-5594

DOI

10.1038/sj.onc.1208036

How to access this item